Hiroyuki Nishikawa

The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation

Rintaro Hashizume, Mamoru Fukuda, Ichiro Maeda et al. · Journal of Biological Chemistry · 2001 · 638 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Takeo Ishiyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 433 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Photoluminescence from defect centers in high-purity silica glasses observed under 7.9-eV excitation

Hiroyuki Nishikawa, Taiji Shiroyama, Ryuta Nakamura et al. · Physical review. B, Condensed matter · 1992 · 408 citations

Natural Sciences, Materials Engineering, Materials Science +17

Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

Peter S. Brzović, Jennifer R. Keeffe, Hiroyuki Nishikawa et al. · Proceedings of the National Academy of Sciences · 2003 · 349 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase

Hiroyuki Nishikawa, Seido Ooka, Ko Sato et al. · Journal of Biological Chemistry · 2004 · 238 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +13